Pfizer Inc. (PFE)
USD 22.34
(1.38%)
USD 22.34
(1.38%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.11 Billion USD | -93.25% |
| 2022 | 31.37 Billion USD | 42.74% |
| 2021 | 21.97 Billion USD | 213.09% |
| 2020 | 7.02 Billion USD | -56.86% |
| 2019 | 16.27 Billion USD | 45.91% |
| 2018 | 11.15 Billion USD | -47.66% |
| 2017 | 21.3 Billion USD | 195.33% |
| 2016 | 7.21 Billion USD | 3.66% |
| 2015 | 6.96 Billion USD | -23.81% |
| 2014 | 9.13 Billion USD | -58.48% |
| 2013 | 22 Billion USD | 51.02% |
| 2012 | 14.57 Billion USD | 45.57% |
| 2011 | 10 Billion USD | 21.22% |
| 2010 | 8.25 Billion USD | -4.38% |
| 2009 | 8.63 Billion USD | 6.55% |
| 2008 | 8.1 Billion USD | -0.49% |
| 2007 | 8.14 Billion USD | -57.88% |
| 2006 | 19.33 Billion USD | 139.17% |
| 2005 | 8.08 Billion USD | -28.84% |
| 2004 | 11.36 Billion USD | 190.56% |
| 2003 | 3.91 Billion USD | -57.16% |
| 2002 | 9.12 Billion USD | 17.18% |
| 2001 | 7.78 Billion USD | 109.02% |
| 2000 | 3.72 Billion USD | 17.21% |
| 1999 | 3.17 Billion USD | -5.13% |
| 1998 | 3.35 Billion USD | 51.42% |
| 1997 | 2.21 Billion USD | 14.72% |
| 1996 | 1.92 Billion USD | 22.64% |
| 1995 | 1.57 Billion USD | 21.14% |
| 1994 | 1.29 Billion USD | 97.48% |
| 1993 | 657.5 Million USD | -18.92% |
| 1992 | 810.9 Million USD | 12.3% |
| 1991 | 722.1 Million USD | -9.87% |
| 1990 | 801.2 Million USD | 17.63% |
| 1989 | 681.1 Million USD | -13.93% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.11 Billion USD | 193.15% |
| 2024 Q2 | 24 Million USD | -99.23% |
| 2024 Q3 | 4.46 Billion USD | 18504.17% |
| 2023 FY | 2.11 Billion USD | -93.25% |
| 2023 Q1 | 5.54 Billion USD | 10.99% |
| 2023 Q2 | 2.32 Billion USD | -58.02% |
| 2023 Q3 | -2.39 Billion USD | -202.88% |
| 2023 Q4 | -3.34 Billion USD | -39.68% |
| 2022 Q3 | 8.6 Billion USD | -13.1% |
| 2022 Q1 | 7.86 Billion USD | 131.77% |
| 2022 Q2 | 9.9 Billion USD | 25.97% |
| 2022 FY | 31.37 Billion USD | 42.74% |
| 2022 Q4 | 4.99 Billion USD | -41.98% |
| 2021 Q1 | 4.87 Billion USD | 721.04% |
| 2021 Q2 | 5.56 Billion USD | 14.07% |
| 2021 Q4 | 3.39 Billion USD | -58.35% |
| 2021 Q3 | 8.14 Billion USD | 46.43% |
| 2021 FY | 21.97 Billion USD | 213.09% |
| 2020 Q1 | 3.35 Billion USD | 1095.55% |
| 2020 Q4 | 594 Million USD | -72.93% |
| 2020 Q3 | 2.19 Billion USD | -37.12% |
| 2020 Q2 | 3.48 Billion USD | 3.99% |
| 2020 FY | 7.02 Billion USD | -56.86% |
| 2019 Q1 | 3.88 Billion USD | 1085.53% |
| 2019 FY | 16.27 Billion USD | 45.91% |
| 2019 Q4 | -337 Million USD | -104.39% |
| 2019 Q3 | 7.68 Billion USD | 52.2% |
| 2019 Q2 | 5.04 Billion USD | 29.95% |
| 2018 Q2 | 3.87 Billion USD | 8.74% |
| 2018 Q1 | 3.56 Billion USD | -70.99% |
| 2018 FY | 11.15 Billion USD | -47.66% |
| 2018 Q4 | -394 Million USD | -109.58% |
| 2018 Q3 | 4.11 Billion USD | 6.28% |
| 2017 Q1 | 3.12 Billion USD | 263.75% |
| 2017 Q4 | 12.27 Billion USD | 332.3% |
| 2017 Q3 | 2.83 Billion USD | -7.61% |
| 2017 Q2 | 3.07 Billion USD | -1.54% |
| 2017 FY | 21.3 Billion USD | 195.33% |
| 2016 FY | 7.21 Billion USD | 3.66% |
| 2016 Q4 | 858 Million USD | -36.68% |
| 2016 Q2 | 2.04 Billion USD | -32.62% |
| 2016 Q3 | 1.35 Billion USD | -33.81% |
| 2016 Q1 | 3.03 Billion USD | 1866.28% |
| 2015 Q1 | 2.37 Billion USD | 93.4% |
| 2015 Q2 | 2.62 Billion USD | 10.57% |
| 2015 Q3 | 2.13 Billion USD | -18.89% |
| 2015 FY | 6.96 Billion USD | -23.81% |
| 2015 Q4 | -172 Million USD | -108.08% |
| 2014 Q3 | 2.66 Billion USD | -8.42% |
| 2014 Q2 | 2.91 Billion USD | 24.99% |
| 2014 Q1 | 2.32 Billion USD | -9.27% |
| 2014 FY | 9.13 Billion USD | -58.48% |
| 2014 Q4 | 1.22 Billion USD | -53.94% |
| 2013 Q4 | 2.56 Billion USD | -1.0% |
| 2013 Q3 | 2.59 Billion USD | -81.61% |
| 2013 Q2 | 14.09 Billion USD | 412.69% |
| 2013 FY | 22 Billion USD | 51.02% |
| 2013 Q1 | 2.75 Billion USD | -56.45% |
| 2012 Q1 | 1.79 Billion USD | 24.67% |
| 2012 Q2 | 3.25 Billion USD | 81.33% |
| 2012 Q3 | 3.2 Billion USD | -1.41% |
| 2012 Q4 | 6.31 Billion USD | 96.91% |
| 2012 FY | 14.57 Billion USD | 45.57% |
| 2011 Q2 | 2.61 Billion USD | 17.46% |
| 2011 FY | 10 Billion USD | 21.22% |
| 2011 Q4 | 1.43 Billion USD | -61.5% |
| 2011 Q3 | 3.73 Billion USD | 43.22% |
| 2011 Q1 | 2.22 Billion USD | -23.11% |
| 2010 Q1 | 2.02 Billion USD | 164.15% |
| 2010 FY | 8.25 Billion USD | -4.38% |
| 2010 Q4 | 2.89 Billion USD | 233.72% |
| 2010 Q3 | 866 Million USD | -65.01% |
| 2010 Q2 | 2.47 Billion USD | 22.16% |
| 2009 Q4 | 767 Million USD | -73.35% |
| 2009 Q2 | 2.26 Billion USD | -17.15% |
| 2009 Q1 | 2.72 Billion USD | 925.94% |
| 2009 Q3 | 2.87 Billion USD | 27.29% |
| 2009 FY | 8.63 Billion USD | 6.55% |
| 2008 Q4 | 266 Million USD | -88.32% |
| 2008 Q2 | 2.77 Billion USD | -0.29% |
| 2008 FY | 8.1 Billion USD | -0.49% |
| 2008 Q3 | 2.27 Billion USD | -17.94% |
| 2008 Q1 | 2.78 Billion USD | 2.24% |
| 2007 Q1 | 3.39 Billion USD | -64.11% |
| 2007 Q3 | 760 Million USD | -39.97% |
| 2007 FY | 8.14 Billion USD | -57.88% |
| 2007 Q2 | 1.26 Billion USD | -62.67% |
| 2007 Q4 | 2.72 Billion USD | 258.29% |
| 2006 Q4 | 9.44 Billion USD | 181.11% |
| 2006 Q2 | 2.41 Billion USD | -41.3% |
| 2006 Q1 | 4.11 Billion USD | 50.53% |
| 2006 FY | 19.33 Billion USD | 139.17% |
| 2006 Q3 | 3.36 Billion USD | 39.29% |
| 2005 Q3 | 1.58 Billion USD | -54.12% |
| 2005 Q2 | 3.46 Billion USD | 1049.83% |
| 2005 Q1 | 301 Million USD | -89.34% |
| 2005 FY | 8.08 Billion USD | -28.84% |
| 2005 Q4 | 2.73 Billion USD | 71.98% |
| 2004 FY | 11.36 Billion USD | 190.56% |
| 2004 Q4 | 2.82 Billion USD | -15.45% |
| 2004 Q3 | 3.34 Billion USD | 16.7% |
| 2004 Q2 | 2.86 Billion USD | 22.83% |
| 2004 Q1 | 2.33 Billion USD | 288.33% |
| 2003 Q2 | -3.59 Billion USD | -176.98% |
| 2003 Q4 | 600 Million USD | -73.14% |
| 2003 Q3 | 2.23 Billion USD | 162.21% |
| 2003 FY | 3.91 Billion USD | -57.16% |
| 2003 Q1 | 4.66 Billion USD | 63.34% |
| 2002 FY | 9.12 Billion USD | 17.18% |
| 2002 Q3 | 2.35 Billion USD | 20.08% |
| 2002 Q1 | 1.96 Billion USD | 0.36% |
| 2002 Q4 | 2.85 Billion USD | 21.53% |
| 2002 Q2 | 1.95 Billion USD | -0.31% |
| 2001 Q1 | 1.93 Billion USD | 35.92% |
| 2001 Q2 | 1.82 Billion USD | -5.23% |
| 2001 Q4 | 1.95 Billion USD | -5.6% |
| 2001 FY | 7.78 Billion USD | 109.02% |
| 2001 Q3 | 2.07 Billion USD | 13.29% |
| 2000 Q2 | 1.15 Billion USD | -2.54% |
| 2000 FY | 3.72 Billion USD | 17.21% |
| 2000 Q4 | 1.42 Billion USD | 4.34% |
| 2000 Q3 | 1.36 Billion USD | 18.35% |
| 2000 Q1 | 1.18 Billion USD | 23.69% |
| 1999 Q1 | 815 Million USD | 28.55% |
| 1999 Q3 | 701 Million USD | -1.13% |
| 1999 FY | 3.17 Billion USD | -5.13% |
| 1999 Q2 | 709 Million USD | -13.01% |
| 1999 Q4 | 954 Million USD | 36.09% |
| 1998 Q1 | 692 Million USD | 24.01% |
| 1998 FY | 3.35 Billion USD | 51.42% |
| 1998 Q2 | 628 Million USD | -9.25% |
| 1998 Q3 | 1.39 Billion USD | 122.45% |
| 1998 Q4 | 634 Million USD | -54.62% |
| 1997 FY | 2.21 Billion USD | 14.72% |
| 1997 Q2 | 457 Million USD | -24.09% |
| 1997 Q3 | 596 Million USD | 30.42% |
| 1997 Q4 | 558 Million USD | -6.38% |
| 1997 Q1 | 602 Million USD | 19.44% |
| 1996 Q1 | 517 Million USD | 25.82% |
| 1996 Q3 | 514 Million USD | 30.46% |
| 1996 Q4 | 504 Million USD | -1.95% |
| 1996 FY | 1.92 Billion USD | 22.64% |
| 1996 Q2 | 394 Million USD | -23.79% |
| 1995 Q3 | 425.3 Million USD | 34.46% |
| 1995 Q1 | 420.4 Million USD | 25.87% |
| 1995 FY | 1.57 Billion USD | 21.14% |
| 1995 Q4 | 410.9 Million USD | -3.39% |
| 1995 Q2 | 316.3 Million USD | -24.76% |
| 1994 Q4 | 334 Million USD | -0.74% |
| 1994 FY | 1.29 Billion USD | 97.48% |
| 1994 Q3 | 336.5 Million USD | 30.83% |
| 1994 Q2 | 257.2 Million USD | -30.62% |
| 1994 Q1 | 370.7 Million USD | 28.31% |
| 1993 Q3 | -214.2 Million USD | -184.4% |
| 1993 Q2 | 253.8 Million USD | -22.86% |
| 1993 Q4 | 288.9 Million USD | 234.87% |
| 1993 FY | 657.5 Million USD | -18.92% |
| 1993 Q1 | 329 Million USD | 2168.97% |
| 1992 FY | 810.9 Million USD | 12.3% |
| 1992 Q3 | 297.5 Million USD | 45.98% |
| 1992 Q2 | 203.8 Million USD | -30.94% |
| 1992 Q1 | 295.1 Million USD | 32688.89% |
| 1992 Q4 | 14.5 Million USD | -95.13% |
| 1991 Q1 | 267.4 Million USD | 72.74% |
| 1991 Q2 | 179.1 Million USD | -33.02% |
| 1991 Q3 | 274.7 Million USD | 53.38% |
| 1991 Q4 | 900 Thousand USD | -99.67% |
| 1991 FY | 722.1 Million USD | -9.87% |
| 1990 FY | 801.2 Million USD | 17.63% |
| 1990 Q4 | 154.8 Million USD | -36.37% |
| 1990 Q3 | 243.3 Million USD | 60.91% |
| 1990 Q2 | 151.2 Million USD | -39.98% |
| 1990 Q1 | 251.9 Million USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | 681.1 Million USD | -13.93% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbbVie Inc. | 4.86 Billion USD | 56.426% |
| Bristol-Myers Squibb Company | 8.02 Billion USD | 73.595% |
| Bristol-Myers Squibb Company Ce | 8.02 Billion USD | 73.595% |
| Johnson & Johnson | 35.15 Billion USD | 93.972% |
| Eli Lilly and Company | 5.24 Billion USD | 59.564% |
| Merck & Co., Inc. | 365 Million USD | -480.548% |
| Novartis AG | 14.85 Billion USD | 85.731% |
| Organon & Co. | 1.02 Billion USD | -107.136% |